Skip to main content

Many Women Continue Using Menopausal Hormone Therapy Beyond Age 65 Years

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 11, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Sept. 11, 2024 -- Many women older than 65 years have validated menopausal symptoms severely affecting their quality of life and continue to use menopausal hormone therapy (MHT), according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.

Meenakshi Goel, M.D., from University of Toronto, and colleagues examined the characteristics and motivations of Canadian women older than 65 years who are still using MHT. The analysis included 110 women seen at the Mature Women’s Health and Menopause Clinic at Mount Sinai Hospital in Toronto.

The researchers found that the mean age of menopause was 50 years, but the mean age for MHT initiation was 52 years. Participants were taking MHT for an average of 18 years, with 42 percent taking MHT for ≥20 years. Controlling vasomotor symptoms (55 percent), better quality of life (29 percent), and a reduction in chronic pain and arthritis symptoms (7 percent) were the most common reasons for continuing MHT beyond 65 years. Nearly two-thirds of women (65.5 percent) never tried to stop MHT due to ongoing symptoms or for better quality of life, while 26.4 percent tried stopping MHT once and 8.2 percent attempted multiple times. More than one-third of women reported postmenopausal bleeding as the most common side effect. The most common adverse events were hip or other fractures (7.3 percent), and two women had ductal carcinoma in situ breast cancer while taking MHT.

“With extensive population-based studies proving various health benefits of MHT beyond 65 years, health practitioners should be more open to considering the continuation of MHT in this age group after appropriate counseling and periodic evaluations for adverse effects/contraindications,” the authors write.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes

FRIDAY, Nov. 1, 2024 -- Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D), according to a research...

ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel Syndrome

THURSDAY, Oct. 31, 2024 -- Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women, according...

Lower Risk for Asthma Seen With Younger Age at Natural Menopause

WEDNESDAY, Oct. 30, 2024 -- Women with younger age at natural menopause have a reduced risk for asthma, according to a study published online Oct. 29 in Menopause. Durmalouk...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.